Last updated on November 2019

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)


Brief description of study

The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice

Clinical Study Identifier: NCT02078427

Find a site near you

Start Over

Hemoce - Ce

Fortaleza, Brazil
  Connect »

Hemepar - Pr

Curitiba, Brazil
  Connect »

Hemorgs - Rs

Porto Alegre, Brazil
  Connect »

Hemorio - Rj

Rio de Janeiro, Brazil
  Connect »

Rigshospitalet

Copenhagen, Denmark
  Connect »

CIC

Saint Priest en Jarez, France
  Connect »

Kantonsspital St. Gallen

St. Gallen, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.